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Lysine deacetylases (KDACs) are enzymes that reverse the post-translational modification
of lysine acetylation. Recently, a series of N-acetylthioureas were synthesized and reported
to enhance the activity of KDAC8 with a fluorogenic substrate. To determine if the activation
was general, we synthesized three of the most potent N-acetylthioureas and measured
their effect with peptide substrates and the fluorogenic substrate under multiple reaction
conditions and utilizing two enzyme purification approaches. No activation was observed
for any of the three N-acetylthioureas under any assayed conditions. Further characteriza-
tion of KDAC8 kinetics with the fluorogenic substrate yielded a kcat/KM of 164 ± 17 in the
absence of any N-acetylthioureas. This catalytic efficiency is comparable to or higher than
that previously reported when KDAC8 was activated by the N-acetylthioureas, suggesting
that the previously reported activation effect may be due to use of an enzyme preparation
that contains a large fraction of inactive enzyme. Further characterization with a less active
preparation and additional substrates leads us to conclude that N-acetylthioureas are not
true activators of KDAC8 and only increase activity if the enzyme preparation is below the
maximal basal activity.
Introduction
Lysine deacetylases (KDACs, also known as histone deacetylases, EC 3.5.1.98) are enzymes that
reverse the post-translational modification of lysine acetylation, by catalyzing the hydrolysis of
ε-N-acetyllysine residues in proteins via a conserved mechanism.[1–3] This cycle of acetylation
and deacetylation has been linked to many biological processes, including development and
growth, memory formation, and regulation of metabolism.[4–7] KDAC activity has also been
linked to numerous diseases, in particular chronic diseases such as asthma, cancers, muscular
disorders, and diabetes.[7–10] KDACs are commonly grouped into several classes, with class I,
II, and IV KDACs being metal-dependent, and class III (sirtuins) being NAD-dependent. Over
1000 inhibitors for KDACs have been identified, and several are in clinical trials or have
already been approved for therapeutic use.[9,11]
There has also been considerable interest in identifying small molecules that activate
KDACs, increasing activity in the presence of a substrate, in particular because most KDACs
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are relatively slow enzymes under in vivo conditions.[12] A variety of natural products have
been identified that stimulate activity of one or more KDACs.[13–16] Recently, several N-acet-
ylthioureas were identified as synthetic activators of KDAC8 with high selectivity and potency,
with a rate enhancement of up to 20-fold.[17,18]
Here, we evaluate the ability of three N-acetylthiourea molecules to activate KDAC8 under
multiple reaction conditions and with multiple substrates. Our findings suggest that these mol-
ecules do not activate KDAC8 unless the enzyme preparation has inherently low activity.
Experimental
Synthesis of N-acetylthioureas
Synthesis was performed as previously described.[17] Briefly, 7.1 mmol of benzoyl chloride
were added over 5 min to 7.8 mmol of room-temperature NH4SCN in 10 mL acetone and the
mixture was heated at reflux for 30 min. Heating was stopped and 7.1 mmol aryl amine (ani-
line, 3,5-dimethoxyaniline, or methylbenzylamine for TM-2-51, TM-2-88, or TM-2-104,
respectively) in acetone were rapidly added to maintain a vigorous reflux. The mixture was
heated for an additional 30 min to maintain reflux. The product was isolated by pouring the
mixture over cracked ice with vigorous stirring until the ice melted, and the resulting solid col-
lected by filtration. The solid was washed with water, cold water/methanol (1:1), and methanol,
then dried at room temperature. TM-2-104 was further purified by silica gel chromatography
and extensively dried to yield the expected oil. Yields of the final products were 60–80%. Stock
solutions were prepared at 10 mmol L-1 in DMSO and stored at -20°C.
Expression and purification of KDAC8
For most assays, KDAC8 was expressed and purified as previously described.[19] Briefly,
KDAC8 was expressed in BL21(DE3) cells using a T5 promoter, then purified by metal affinity
chromatography with Talon cobalt resin (Clontech) using a batch/column method. Protein
was washed in 30 mmol L-1 MOPS pH 8.0, 150 mmol L-1 KCl, and 5.0 mmol L-1 imidazole,
then eluted in the same buffer containing 150 mmol L-1 imidazole. Following initial purifica-
tion, the His6 tag was cleaved using tobacco etch virus protease during dialysis and the resulting
enzyme isolated by eliminating contaminants using a second metal affinity column. Enzymes
were stored in 30 mmol L-1 MOPS pH 8.0, 150 mmol L-1 KCl, 25% glycerol, and 1 mmol L-1
tris(2-carboxyethyl)phosphine. Where noted, KDAC8 was expressed identically then purified
using Ni Superflow Resin (Clontech) instead of cobalt resin. This method was identical to that
previously described except that wash buffer contained 20 mmol L-1 imidazole, elution buffer
contained 300 mmol L-1 imidazole, and the tag cleavage step and second column were skipped;
protein was dialyzed directly into the storage buffer following the initial purification. All assays
described below were performed using multiple, independently expressed batches of enzyme.
KDAC8 expressed in a baculovirus system with a C-terminal His6 tag was purchased (BPS Bio-
science) and dialyzed into 30 mmol L-1 MOPS pH 8.0, 150 mmol L-1 KCl, and 25% glycerol,
then stored in the same buffer with addition of 1 mmol L-1 tris(2-carboxyethyl)phosphine. Pro-
tein purity was assessed by SDS-PAGE and stained with GelCode Blue (Thermo Scientific).
Fluorescamine assay
Peptides were synthesized (Genscript) and purified to> 95%. Reaction conditions were as pre-
viously described.[19] Briefly, 200 nmol L-1 KDAC8 and 100 μmol L-1 peptide were incubated
in assay buffer 1 (30 mmol L-1 potassium phosphate pH 7.6, 100 mmol L-1 KCl, and 5% glyc-
erol) for 1 hr at 25°C in the absence or presence of 10 μmol L-1 N-acetylthiourea, stopped with
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100 μmol L-1 suberoylanilide hydroxamine (SAHA), and product formation was monitored by
addition of fluorescamine. Errors represent the standard deviation of three independent
experiments.
Fluor-de-Lys assay
Reaction conditions were as previously described,[17] with the following variations. 200 nmol
L-1 KDAC8 and 100 μmol L-1 Fluor-de-Lys substrate (Enzo Life Sciences) were incubated in
assay buffer 1, assay buffer 2 (50 mmol L-1 tris pH 8.0, 137 mmol L-1 NaCl, 2.7 mmol L-1 KCl,
and 1 mg mL-1 BSA), or assay buffer 3 (30 mmol L-1 MOPS pH 8.0, 150 mmol L-1 KCl, and 5%
glycerol), as noted, for 1 hr at 25°C in the absence or presence of 10 μmol L-1 N-acetylthiourea.
Reactions with the Fluor-de-Lys HDAC8 substrate (Enzo Life Sciences) utilized 150 nmol L-1
KDAC8 and 150 μmol L-1 substrate incubated in assay buffer 4 (25 mmol L-1 tris pH 8.2, 137
mmol L-1 NaCl, 2.7 mmol L-1 KCl, and 1.0 mmol L-1 MgCl2) for 10 min at 25°C in the absence
or presence of 100 μmol L-1 TM-2-51. Reactions were stopped by addition of SAHA to a final
concentration of 100 μmol L-1 and trypsin to a final concentration of 1 mg mL-1, then incu-
bated at 37°C for 15 min before being read in a 96 well plate with 360 nm excitation and
460 nm emission at 25°C. Fluorescence was converted to activity using a standard curve of the
free 7-amino-4-methylcoumarin. Where noted, Zn2+ or Co2+ (ICP-MS standard quality, Ultra
Scientific) were pre-incubated with the enzyme prior to addition of substrate. Errors represent
the standard deviation of three to six independent experiments, except where noted.
Steady-state kinetics
140 nmol L-1 KDAC8 and various concentrations of Fluor-de-Lys substrate were incubated as
described for the Fluor-de-Lys assay in assay buffer 2. Aliquots were mixed with SAHA to stop
reactions at 0, 15, 30, and 45 min, then all aliquots were treated with trypsin simultaneously.
The resulting data was non-linearly fit to the Michaelis-Menten equation as previously
described.[19]
Results
The synthetic N-acetylthiourea products (Fig 1) match the data previously reported for the
molecules except for the colors of the solids TM-2-51 and TM-2-88. These powders were origi-
nally described as yellow and white, respectively,[17] but we observed the colors to be swapped.
However, all NMR and melting point data on our synthesized molecules agree with the previ-
ous report (S1–S4 Tables). To determine the effect of the N-acetylthioureas on the activity of
KDAC8 with peptide substrates, deacetylation of peptides was evaluated in the presence or
absence of the N-acetylthioureas. The peptides used here have been previously shown to be
Fig 1. Structures of the N-acetylthioureas evaluated.Molecules were synthesized as described in the Experimental section, and data validating synthesis
is provided as supplemental information.
doi:10.1371/journal.pone.0146900.g001
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substrates for KDAC8.[19,20] As shown in Table 1, the N-acetylthioureas failed to increase
activity when added to the reaction at 10 μmol L-1. Increasing the concentration of each N-
acetylthiourea to 100 μmol L-1 also failed to increase enzyme activity above the activity level
observed in the absence of the molecules.
To evaluate if the effect of the N-acetylthioureas was specific to the Fluor-de-Lys substrate
and/or particular buffer conditions, we performed the Fluor-de-Lys assay with and without N-
acetylthioureas present, in both the phosphate buffer used with the peptide substrates and the
standard Fluor-de-Lys buffer as previously reported. Again, we did not observe any significant
activation of the enzymes by the N-acetylthioureas (Table 2). To ensure that the lack of effect
was not due to the different purification protocol that we utilized,[19] we purified another
batch of KDAC8 using Ni Superflow resin similarly to the method previously described.[17]
The enzyme purified on nickel resin was significantly less pure than that purified by our stan-
dard method (S1 Fig). The resulting protein was also unaffected by N-acetylthioureas
(Table 2), and exhibited approximately 4-fold lower activity than the enzyme prepared using
our standard method. To determine if this lack of activation was independent of our enzyme
purification process, we performed the same experiments with a commercial preparation of
KDAC8. The baseline activity of this preparation was lower, but statistically significant 1.5- to
2-fold activation was observed (Table 2). Both spectroscopic methods and gel electrophoresis
(S1 Fig) were used to confirm that the concentrations of enzyme used in these reactions were
the same.
It has previously been reported that KDAC8 is inhibited by excess concentrations of zinc
(i.e., addition of zinc beyond the concentration necessary to saturate the active site).[2] We
considered that the N-acetylthioureas could potentially activate KDAC8 by reversing this inhi-
bition, and therefore tested the effect of the molecules in the presence of excess Zn2+. There
was no effect of the N-acetylthioureas in the presence of excess Zn2+ under these conditions
(Table 3). However, we were also surprised to observe no significant inhibition by zinc inde-
pendent of the N-acetylthioureas, and so performed a titration of Zn2+ in assay buffer 3, which
more closely resembled the conditions used when zinc inhibition was reported.[2] KDAC8
does show the expected zinc inhibition in this buffer (Fig 2). It is likely that a composition
change in the two buffers, such as overall salt concentration or the presence of BSA, causes this
difference in zinc inhibition. In contrast, titrating in excess cobalt had no effect on the enzyme
activity in any assay buffer, as expected.[2] Together, the results of the zinc and cobalt titrations
Table 1. Effect of N-acetylthioureas on KDAC8 activity with peptide substrates in assay buffer 1.
Activity (pmol min-1 μg-1)
Substrate No N-acetylthiourea 10 μmol L-1 TM-2-51 10 μmol L-1 TM-2-88 10 μmol L-1 TM-2-104
ac-FR-{K-ac}-RW-am 21.0 ± 1.3 20.3 ± 2.1 19.6 ± 1.9 19.7 ± 1.4
ac-IS-{K-ac}-FD-am 10.0 ± 2.6 9.9 ± 2.7 9.8 ± 2.9 9.9 ± 2.7
doi:10.1371/journal.pone.0146900.t001
Table 2. Effect of N-acetylthioureas on KDAC8 activity with Fluor-de-Lys substrate.
Activity (pmol min-1 μg-1)
Buffer Enzyme preparation No N-acetylthiourea 10 μmol L-1 TM-2-51 10 μmol L-1 TM-2-88 10 μmol L-1 TM-2-104
Assay buffer 1 Co2+ resin, cleaved His6 3.7 ± 0.4 4.5 ± 0.4 4.4 ± 0.9 4.4 ± 0.3
Assay buffer 2 Co2+ resin, cleaved His6 18.2 ± 3.4 21.9 ± 4.3 21.0 ± 2.4 17.8 ± 2.7
Assay buffer 2 Ni2+ resin, His6 tagged 5.3 ± 1.4 4.9 ± 1.0 4.6 ± 1.0 4.5 ± 1.3
Assay buffer 1 Commercial, His6 tagged 0.35 ± 0.04 0.68 ± 0.14 0.81 ± 0.26 0.54 ± 0.11
doi:10.1371/journal.pone.0146900.t002
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indicate that our preparation of KDAC8 results in a protein with an active site saturated with
metal. Regardless, Table 3 clearly shows that the N-acetylthioureas still have no effect in the
presence of excess zinc under the conditions previously reported.[17,18]
We also determined the steady-state parameters for KDAC8 with the Fluor-de-Lys substrate
(Table 4, Fig 3). Our results indicate about a two-fold lower substrate affinity than that previ-
ously reported.[18] Our observed kcat, without any N-acetylthiourea, is three-fold higher than
that previously reported for the activated KDAC8 and approximately 30-fold higher than pre-
viously reported for the enzyme in the absence of the N-acetylthioureas (Table 4). In addition,
the catalytic efficiency of our preparation of the enzyme is equal to or greater than that previ-
ously reported for the enzyme with N-acetylthiourea TM-2-51 (Table 4).
Independent use of 100 μmol L-1 of the N-acetylthiourea TM-2-51 was recently reported
with a range of KDAC8 variants with the Fluor-de-Lys HDAC8 substrate.[21,22] In all cases,
1.5- to 3-fold activation was reported, similar to what we observed with the commercial
KDAC8 preparation. We attempted to replicate these results using our enzyme preparation
and identical reaction conditions. Again no activation was observed with our enzyme prepara-
tion (Table 5). Our basal activity with the Fluor-de-Lys HDAC8 substrate without TM-2-51
was also substantially higher than the activity previously reported with the N-acetylthiourea,
similar to the difference observed between our preparation and the commercial preparation.
Table 3. Effect of N-acetylthioureas on KDAC8 Activity with Fluor-de-Lys substrate in assay buffer 2 in the presence of excess zinc.
Activity (pmol min-1 μg-1)
Concentration of zinc (fold excess) No N-acetylthiourea 10 μmol L-1 TM-2-51 10 μmol L-1 TM-2-88 10 μmol L-1 TM-2-104
0 nmol L-1 (0X) 18.2 ± 3.4 21.9 ± 4.3 21.0 ± 2.4 17.8 ± 2.7
200 nmol L-1 (1X) 18.5 ± 1.1 19.7 ± 2.1 18.2 ± 0.9 18.1 ± 0.3
400 nmol L-1 (2X) 17.6 ± 1.9 21.7 ± 4.0 19.4 ± 1.7 20.1 ± 4.4
doi:10.1371/journal.pone.0146900.t003
Fig 2. Effect of Zn2+ on activity of KDAC8. KDAC8 was incubated with Fluor-de-Lys substrate in assay
buffer 3 with 0-10X excess Zn2+, as detailed in the Experimental section. The rapid decline in activity
indicates that even a small amount of excess zinc is binding to the low affinity inhibitory site, indicating active
site saturation. Error bars represent the standard deviation of technical triplicates.
doi:10.1371/journal.pone.0146900.g002
Lack of N-Acetylthiourea Activation
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Discussion
The mechanism of activation by small molecules of lysine deacetylases is not fully understood,
and has been the focus of considerable controversy (reviewed in [23]). The most potent natural
product activator for any lysine deacetylase identified to date, resveratrol, has effects that are
strongly substrate-dependent and most effective with unnatural dye-labeled substrates such as
Fluor-de-Lys.[23–25] We were interested in whether the same effect was observed with activa-
tors of KDAC8, as the interaction between substrate and activator would lead to greater insight
into the biological activity of the enzyme.
Our initial screening using a label-free assay system with peptides known to be substrates
for KDAC8 revealed no increase in activity by N-acetylthioureas (Table 1). However, our reac-
tion conditions were also different than those used to identify N-acetylthioureas as activating
molecules, and so we sought to determine whether the lack of activation was due to substrate-
specific effects or buffer-specific effects. Unexpectedly, the results indicated that three of the
N-acetylthioureas previously described as the most potent KDAC8 activators failed to activate
Table 4. Steady-state kinetics parameters for Fluor-de-Lys substrate with KDAC8 in assay buffer 2.
N-acetylthiourea kcat (s
-1) KM (μmol L
-1) kcat/KM (L mol
-1 s-1)
None a 0.208 ± 0.017 1270 ± 190 164 ± 17
None b 0.007 744 9.4
None c 0.007 ± 0.001 650 ± 20 10.8 ± 1.6
Saturating TM-2-51 b 0.036 230 150
10 μmol L-1 TM-2-51 c 0.072 ± 0.014 580 ± 26 124 ± 25
a This work.
b From reference [17].
c From reference [18].
doi:10.1371/journal.pone.0146900.t004
Fig 3. Steady-state kinetics of KDAC8 with Fluor-de-Lys substrate. KDAC8 was incubated with several
concentrations of Fluor-de-Lys substrate in assay buffer 2. Aliquots were removed and stopped at various
timepoints to determine the initial deacetylation rate for each reaction. Concentration was plotted against
initial rate and non-linearly fit to the Michaelis-Menten equation. Steady-state kinetics parameters (Table 4)
were calculated from these data.
doi:10.1371/journal.pone.0146900.g003
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our KDAC8 preparation even under the original reaction conditions and with the same sub-
strate (Table 2). To further eliminate possible sources of variability, we prepared multiple
batches of enzyme, including one under purification conditions that more closely reproduced
the original conditions. The motivation was that because the enzyme is metal-dependent, it is
possible that the metal content of the enzyme was influenced by the particular type of metal
affinity chromatography utilized and/or the presence of the His6 tag. Modification of the purifi-
cation conditions reduced the overall enzyme activity approximately four-fold (Table 2), con-
sistent with some introduction of Ni2+ into the enzyme,[2] but did not generate conditions
where activation was observed. It is also possible that some impurities present from the nickel-
purified protein contribute to the apparent reduction in activity compared to the cobalt-puri-
fied/tag-cleaved enzyme. Even lower basal activity was observed with a His6-tagged commercial
preparation of KDAC8. However, with the commercial preparation, up to 2-fold activation
was observed (Table 2), although this still far below the 5- to 20-fold activation previously
reported.[17,18] Somewhat less activation was observed with TM-2-104, consistent with the
prior report that this was the least potent of these three N-acetylthioureas.[17] This observation
of preparation-dependent activation indicates that activation of N-acetylthioureas is dependent
on some variation in enzyme preparation.
An alternate mechanism by which metals might play a role in apparent activation is that
Zn2+ is known to inhibit KDAC8 when present in excess by binding to a second site in the pro-
tein.[2] To test the hypothesis that N-acetylthioureas might be “activating” KDAC8 by revers-
ing excess metal inhibition, we also determined the effect of the N-acetylthioureas in the
presence of excess zinc. However, the buffer used to originally demonstrate activation, assay
buffer 2, eliminates the inhibition by Zn2+ (compare Table 3 and Fig 2), perhaps due to non-
specific metal binding by BSA attributable to the relatively large excess of BSA compared to
enzyme and zinc. Given the lack of inhibition by Zn2+ in assay buffer 2, it is not surprising that
we did not observe any reversal of metal inhibition by the N-acetylthioureas (Table 3).
To rule out problems with our enzyme preparation, we sought to compare the activity of
our enzyme directly to those values previously reported with the N-acetylthioureas.[17,18]
Unfortunately, most of the activity measurements for these experiments were reported in
terms of fluorescence units, which is instrument-dependent and therefore not comparable
between laboratories, or as normalized fold-activation. However, steady-state parameters of
KDAC8 with Fluor-de-Lys in the absence and presence of one of the N-acetylthioureas, TM-2-
51, have been reported.[18] We obtained steady-state parameters for our preparation of
KDAC8 with the Fluor-de-Lys substrate under identical conditions in the absence of any N-
acetylthiourea. Interestingly, Singh and coworkers report a large increase in kcat in the presence
Table 5. Effect of TM-2-51 on KDAC8 activity with Fluor-de-Lys HDAC8 substrate in assay buffer 4.
Activity (pmol min-1 μg-1)
Source No N-acetylthiourea 100 μmol L-1 TM-2-51
This work 450 ± 50 430 ± 130
Reference [21] a 28 ± 1 66 ± 2
Reference [22] a 27 ± 1 56 ± 2
Reference [2] b 820 ± 140 Not reported
a Converted from the units originally reported using the molecular mass of our KDAC8.
b Calculated from reported kcat and KM values. Reaction temperature was 37°C, which has been previously
reported to approximately double the reaction rate compared to 25°C.[19]
doi:10.1371/journal.pone.0146900.t005
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of TM 2–51. Our calculated kcat in the absence of any N-acetylthiourea is significantly greater
than the “activated” kcat that they report, and our catalytic efficiency is at least as high as the
reported “activated” efficiency (Table 4). Therefore, our preparation of enzyme may be insensi-
tive to the N-acetylthioureas because it is already operating at the maximum rate, so no addi-
tional activation is possible. It is probable that our much higher kcat is due to differences in the
amount and/or type of metal contained in the enzyme (Ni2+, Zn2+, or Co2+), with the Ni2+
enzyme expected to be slower than the others.[2] Although our observed KM is approximately
twice that previously reported,[18] our kinetic parameters are well within the range of values
previously reported for similar coumarin-labeled substrates.[2,26,27] Moreover, previous data
indicate that the KM is sensitive to the metal present in the active site,[2] so the difference in
KM values may also indicate a difference in enzyme metal content.
Further evidence that activation may depend on the baseline activity of the enzyme prepara-
tion comes from a comparison to recent reports by an independent research group of activa-
tion by TM-2-51. In these reports, KDAC8 prepared similarly to our method was shown to be
activated up to approximately 2-fold by up to 100 μmol L-1 TM-2-51. A direct comparison of
the activity of our enzyme preparation with these reported conditions again confirms that we
do not see activation with our enzyme preparation, even using the Fluor-de-Lys HDAC8 sub-
strate and the higher concentration of TM-2-51 (Table 5). However, as in the other cases, our
basal activity is also higher than the “activated” level reported. Therefore, analysis of indepen-
dent preparations of enzyme, reaction conditions, and substrates reveals that lower basal
enzyme activity correlates with greater activation by N-acetylthioureas: the enzyme with the
lowest basal activity, reported by Singh et. al., was activated up to 10-fold more than the prepa-
rations with intermediate activity, and no activation is observed with our preparations with the
highest basal activity. Critically, in no case does an “activated” preparation exceed the highest
basal activity (i.e., in the absence of any N-acetylthiourea) that we observed, and our high activ-
ity preparation results in activity data that is comparable to other reports in the literature
(Table 5 and discussed for other substrates in ref [19]).
Therefore, we conclude that the reported activation of KDAC8 by N-acetylthioureas is likely
to be due to a specific feature of the preparation of the enzyme rather than a general mecha-
nism, and any biological effects of N-acetylthioureas are unlikely to be due to interactions with
KDAC8. In the initial report, it was noted that the N-acetylthioureas had no effect or slight
inhibition with all tested KDACs except KDAC8.[17] Our preparation of KDAC8 therefore
exhibits behavior consistent with all other KDACs, suggesting that the apparent activation of
KDAC8 by the N-acetylthioureas is a function of the specific method used to prepare that
enzyme instead of a true activation. It is possible that this preparation effect may have a corre-
lation with the metal content of the enzyme, and that the N-acetylthioureas only serve as acti-
vators when the enzyme is partially metal-depleted (i.e., consistent with the lower baseline kcat
reported by Singh and coworkers) and that even the fully “active” enzyme contains Ni2+ and
exhibits sub-optimal activity.[18] However, in the absence of reported data evaluating metal
content for enzyme preparations that show activation by the N-acetylthioureas, such as direct
determination of metal content by ICP-MS or indirect demonstration of metal saturation by
zinc titrations, we are unable to test this hypothesis. Alternatively, perhaps N-acetylthioureas
help stabilize a particular conformation of KDAC8 that is more active, and the enzyme prepa-
ration conditions influence how much of this conformation is present. Although we have not
identified a specific mechanism of action, it is clear that the activation effect of N-acetylthiour-
eas is preparation-dependent and should more appropriately be described as partially reversing
a deficiency in the basal activity than true activation.
Lack of N-Acetylthiourea Activation
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Supporting Information
S1 Fig. Purified KDAC8. (A) 1 μg KDAC8 purified as described in materials and methods was
subjected to SDS-PAGE and stained with GelCode Blue. Center lane is the enzyme purified
using cobalt resin following tag cleavage with tobacco etch virus protease, with an expected
mass of 42.5 kDa. Right lane is the enzyme purified using nickel resin and without cleaving the
tag, as described in the experimental section, with an expected mass of 43.4 kDa. Under the
staining conditions, all bands of at least 10 ng would appear. The cobalt-purified protein is sub-
stantially more pure than the nickel-purified protein. (B) 1 μg of an independent preparation
of KDAC8 purified with cobalt resin (center) and 1 μg of commercial KDAC8. The purity of
our KDAC8 is consistent across batches, and is at least as high as that of the commercial prepa-
ration (expected mass 46.4 kDa). Equivalent intensity in the two lanes on this gel indicates that
enzyme concentrations determined by spectroscopic methods are internally consistent.
(PDF)
S1 Table. Comparison of expected and measured 1H-NMR spectrum for TM-2-51.
(PDF)
S2 Table. Comparison of expected and measured 1H-NMR spectrum for TM-2-88.
(PDF)
S3 Table. Comparison of expected and measured 1H-NMR spectrum for TM-2-104.
(PDF)
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S1 Fig.  Purified KDAC8.  (A) 1 µg KDAC8 purified as described in materials and methods was 
subjected to SDS-PAGE and stained with GelCode Blue.  Center lane is the enzyme purified using cobalt 
resin following tag cleavage with tobacco etch virus protease, with an expected mass of 42.5 kDa.  Right
lane is the enzyme purified using nickel resin and without cleaving the tag, as described in the 
experimental section, with an expected mass of 43.4 kDa.  Under the staining conditions, all bands of at 
least 10 ng would appear.  The cobalt-purified protein is substantially more pure than the nickel-
purified protein.  (B) 1 µg of an independent preparation of KDAC8 purified with cobalt resin (center) 
and 1 µg of commercial KDAC8.  The purity of our KDAC8 is consistent across batches, and is at least as 
high as that of the commercial preparation (expected mass 46.4 kDa).  Equivalent intensity in the two 
lanes on this gel indicates that enzyme concentrations determined by spectroscopic methods are 
internally consistent.
S1 Table.  Comparison of expected and measured 1H-NMR spectrum for TM-2-51. 
 
Proton(s) 
Expected δ (ppm) a 
Acetone-D6, 400 MHz 
Measured δ (ppm) 
Acetone-D6, 300 MHz 
N - b - b 
N’ 10.3 (bs, 1H) - b 
C3, C7 8.06 - 8.04 (m, 2H) 8.11 - 8.08 (m, 2H) 
C2’, C6’ 7.78 - 7.76 (m, 2H) 7.84 - 7.81 (m, 2H) 
C5 7.69 - 7.64 (m, 1H) 7.72 - 7.69 (m, 1H) 
C4, C6 7.57 - 7.53 (m, 2H) 7.63 - 7.60 (m, 2H) 
C3’, C5’ 7.43 - 7.38 (m, 2H) 7.48 - 7.45 (m, 2H) 
C4’ 7.28 - 7.24 (m, 1H) 7.32 - 7.27 (m, 1H) 
 
a From reference [17]. 
b Not observed. 
 
S2 Table.  Comparison of expected and measured 1H-NMR spectrum for TM-2-88. 
 
Proton(s) 
Expected δ (ppm) a 
Acetone-D6, 300 MHz 
Measured δ (ppm) 
Acetone-D6, 300 MHz 
N 12.86 (bs, 1H) 12.87 (bs, 1H) 
N’ 10.27 (bs, 1H) 10.27 (bs, 1H) 
C3, C7 8.08 (d, J = 7.8 Hz, 2H) 8.10 (d, 2H) 
C4, C5, C6 7.73 - 7.56 (m, 3H) 7.74 - 7.59 (m, 3H) 
C2’, C6’ 7.11 (d, J = 2.4 Hz, 2H) 7.13 (s, 2H) 
C4’ 6.42 - 6.40 (m, 1H) 6.43 - 6.41 (m, 1H) 
Methoxy 3.81 (s, 6H) 3.82 (s, 6H) 
 
a From reference [17]. 
 
S3 Table.  Comparison of expected and measured 1H-NMR spectrum for TM-2-104. 
 
Proton(s) 
Expected δ (ppm) a 
CDCl3, 400 MHz 
Measured δ (ppm) 
CDCl3, 300 MHz 
N 10.90 (d, J = 6.4 Hz, 1H) 11.02 (d, 1H) 
N’ 8.75 (bs, 1H) 9.02 (bs, 1H) 
C3, C7 7.63 - 7.61 (m, 2H) 7.70 - 7.67 (m, 2H) 
C5 7.43 - 7.39 (m, 1H) 7.48 - 7.43 (m, 1H) 
C5’, C7’ 7.33 - 7.28 (m, 2H) 7.36 - 7.31 (m, 2H) 
C4, C6, C4’, C8’ 7.21 - 7.15 (m, 4H) 7.25 - 7.23 (m, 4H) 
C6’ 7.11 - 7.07 (m, 1H) 7.17 - 7.11 (m, 1H) 
C2’ 5.45 - 5.38 (m, 1H) 5.54 - 5.44 (m, 1H) 
C1’ 1.46 (d, J = 6.8 Hz, 3H) 1.53 (d, 3H) 
 
a From reference [17]. 
 
 
S4 Table.  Comparison of expected and measured melting point temperatures of the N-acetylthioureas. 
 
 Melting point (°C) 
N-acetylthiourea Expected a Measured 
TM-2-51 148 - 150 144 - 146 
TM-2-88 154 - 156 152 - 155 
TM-2-104 - b - b 
 
a From reference [17]. 
b Not measured, as the melting temperature is below room temperature. 
